Research advances in the treatment for uveal melanoma / 眼科新进展

ABSTRACT

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.Despite the availability of local treatment modalities,the survival rates of patients with UM have not improved in 30 years.And the main reason is lack of therapeutic drugs for UM,especially agents that inhibit tumor metastasis.Foreign researchers have carried out extensive clinical trials on the agents,but traditional ocular enucleation has been performed for the treatment of UM without any clinical drug tests in China.This paper will give a review on these clinical trials abroad,hoping to provide insight in the treatment of UM for domestic ophthalmologists and oncologist.